Annual Review of Pharmacology and Toxicology

Annual Review of Pharmacology and Toxicology(英文缩写 ANNU REV PHARMACOL),ISSN 0362-1642,eISSN 1545-4304 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
19.000
JCR 分区
Q1
CAS 分区
B1
近一年发文量
0

指标来源:jcr_cas_ifqb

ISSN: 0362-1642 · eISSN: 1545-4304 · 缩写: ANNU REV PHARMACOL

期刊简介

暂无简介。

历年影响因子趋势

年份影响因子JCR 分区
-Q1
-Q1
-Q1
-Q1
-Q1

Annual Review of Pharmacology and Toxicology 最新收录文献

※ 中文译文由 AI 辅助生成,仅供学术参考,请以英文原文为准。

  1. Mycobacterial subversion of chemotherapeutic reagents and host defense tactics: challenges in tuberculosis drug development.

    Recent worldwide emergence of multidrug-resistant and extensively drug-resistant tuberculosis is threatening to destabilize tuberculosis control programs and urging global attention to the development…

    查看详情 DOI
  2. The TRPC class of ion channels: a critical review of their roles in slow, sustained increases in intracellular Ca(2+) concentrations.

    The realization that there exists a multimembered family of cation channels with structural similarity to Drosophila's Trp channel emerged during the second half of the 1990s. In mammals, depending on…

    查看详情 DOI
  3. Topical microbicides to prevent HIV: clinical drug development challenges.

    Microbicides, substances applied topically to prevent sexual HIV infection, are needed to empower receptive sexual partners with effective prevention methods. Several large microbicide trials, however…

    查看详情 DOI
  4. Akt/GSK3 signaling in the action of psychotropic drugs.

    Psychotropic drugs acting on monoamine neurotransmission are major pharmacological treatments for neuropsychiatric conditions such as schizophrenia, depression, bipolar disorder, Tourette syndrome, AD…

    查看详情 DOI
  5. Emerging pharmacology: inhibitors of human immunodeficiency virus integration.

    The first integrase inhibitor licensed to treat HIV-1 infection was approved in late 2007, more than a decade after the introduction of the first inhibitors of the HIV-1 reverse transcriptase and prot…

    查看详情 DOI
  6. Immunodrugs: therapeutic VLP-based vaccines for chronic diseases.

    Worldwide, the prevalence of noncommunicable chronic diseases is increasing. The use of vaccines to induce autoantibodies that neutralize disease-related proteins offers a means to effectively and aff…

    查看详情 DOI
  7. Quantitative disease, drug, and trial models. 定量疾病、药物和试验模型

    Quantitative disease-drug-trial models allow learning from prior experience and summarize the knowledge in a ready to apply format. Employing these models to plan future development is proposed as a p…

    查看详情 DOI
  8. The COXIB experience: a look in the rearview mirror.

    Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used prescription and nonprescription drugs in the world. The discovery of cyclooxygenase (COX) as the target of NSAIDs, the su…

    查看详情 DOI
  9. Epigenetics, DNA methylation, and chromatin modifying drugs.

    Evidence is emerging that several diseases and behavioral pathologies result from defects in gene function. The best-studied example is cancer, but other diseases such as autoimmune disease, asthma, t…

    查看详情 DOI
  10. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. 尼古丁药理学:成瘾、吸烟引起的疾病和治疗

    Nicotine sustains tobacco addiction, a major cause of disability and premature death. Nicotine binds to nicotinic cholinergic receptors, facilitating neurotransmitter release and thereby mediating the…

    查看详情 DOI

在 Annual Review of Pharmacology and Toxicology 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊